Personalized circulating tumor DNA–based minimal residual disease assessment for optimizing interval debulking surgery timing in advanced ovarian cancer: toward precision surgical oncology

International Journal of Gynecological Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles